LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 211 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $169,447 | +36.0% | 2,011 | +18.0% | 0.00% | 0.0% |
Q1 2024 | $124,562 | -54.7% | 1,704 | -55.7% | 0.00% | 0.0% |
Q4 2023 | $274,824 | +315.8% | 3,848 | +248.9% | 0.00% | +50.0% |
Q3 2023 | $66,092 | +182.9% | 1,103 | +240.4% | 0.00% | +100.0% |
Q2 2023 | $23,360 | +61373.7% | 324 | -37.6% | 0.00% | 0.0% |
Q1 2023 | $38 | -51.3% | 519 | -55.3% | 0.00% | -66.7% |
Q4 2022 | $78 | -100.0% | 1,161 | -66.8% | 0.00% | -40.0% |
Q3 2022 | $301,000 | -39.8% | 3,492 | -37.7% | 0.01% | -54.5% |
Q2 2022 | $500,000 | +147.5% | 5,601 | +211.9% | 0.01% | +450.0% |
Q1 2022 | $202,000 | -63.5% | 1,796 | -49.9% | 0.00% | -80.0% |
Q4 2021 | $554,000 | +179.8% | 3,587 | +152.8% | 0.01% | +100.0% |
Q3 2021 | $198,000 | +47.8% | 1,419 | +39.0% | 0.01% | +66.7% |
Q2 2021 | $134,000 | -21.6% | 1,021 | -8.9% | 0.00% | 0.0% |
Q1 2021 | $171,000 | +98.8% | 1,121 | +29.1% | 0.00% | 0.0% |
Q4 2020 | $86,000 | -30.1% | 868 | -33.0% | 0.00% | +200.0% |
Q3 2020 | $123,000 | -68.5% | 1,295 | -62.9% | 0.00% | -93.8% |
Q2 2020 | $390,000 | +19400.0% | 3,491 | +11536.7% | 0.02% | – |
Q1 2020 | $2,000 | -99.1% | 30 | -98.7% | 0.00% | -100.0% |
Q4 2019 | $232,000 | +792.3% | 2,227 | +759.8% | 0.02% | +850.0% |
Q3 2019 | $26,000 | 0.0% | 259 | +13.6% | 0.00% | 0.0% |
Q2 2019 | $26,000 | +160.0% | 228 | +188.6% | 0.00% | +100.0% |
Q1 2019 | $10,000 | -63.0% | 79 | -60.3% | 0.00% | -50.0% |
Q4 2018 | $27,000 | +800.0% | 199 | +1226.7% | 0.00% | – |
Q2 2018 | $3,000 | -85.0% | 15 | -89.6% | 0.00% | -100.0% |
Q4 2017 | $20,000 | -89.8% | 144 | -90.0% | 0.00% | -81.2% |
Q3 2017 | $197,000 | +579.3% | 1,445 | +514.9% | 0.02% | +433.3% |
Q2 2017 | $29,000 | +45.0% | 235 | +20.5% | 0.00% | +50.0% |
Q4 2016 | $20,000 | +81.8% | 195 | +74.1% | 0.00% | +100.0% |
Q3 2016 | $11,000 | -21.4% | 112 | -7.4% | 0.00% | 0.0% |
Q2 2016 | $14,000 | -22.2% | 121 | -27.5% | 0.00% | -66.7% |
Q4 2015 | $18,000 | -43.8% | 167 | -47.5% | 0.00% | 0.0% |
Q2 2015 | $32,000 | -74.4% | 318 | -80.4% | 0.00% | -80.0% |
Q1 2015 | $125,000 | +681.2% | 1,622 | +440.7% | 0.02% | +650.0% |
Q4 2014 | $16,000 | +23.1% | 300 | +9.5% | 0.00% | +100.0% |
Q3 2014 | $13,000 | -74.5% | 274 | -66.5% | 0.00% | -85.7% |
Q2 2014 | $51,000 | +240.0% | 819 | +265.6% | 0.01% | +250.0% |
Q1 2014 | $15,000 | +1400.0% | 224 | +729.6% | 0.00% | – |
Q3 2013 | $1,000 | -98.8% | 27 | -98.8% | 0.00% | -100.0% |
Q2 2013 | $86,000 | – | 2,302 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |